Ampio Pharmaceuticals (AMPE) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Ampio Pharmaceuticals, Inc. has announced the successful completion of its recent nonclinical studies in a press release dated February 14, 2024. The company emphasizes that the information provided should not be considered part of the formal financial filings required by the SEC, but it serves to keep investors informed about its latest research developments.
For further insights into AMPE stock, check out TipRanks’ Stock Analysis page.
